Prometheus brings you some freaky patents that are not for the soft-hearted with a few of them verging to the point of cruelty. The following are our previous articles in the series of freaky patents:
Prometheus brings you some freaky patents that are not for the soft-hearted with a few of them verging to the point of cruelty. The following are our previous articles in the series of freaky patents:
The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of patent rights. The court’s order is with reference to a complaint filed by Micromax and Intex with the CCI against Ericsson. For more information, click here.
Prometheus brings you some freaky patents for the lazybones in continuation of our series on freaky patents. Do you have any ideas like these patented ideas?!?! Come to Prometheus to get them patented. One can never say which idea will be commercially successful.
MediciNova, a US biopharmaceutical company has been granted a US patent for its new drugs targeting hypertriglyceridemia, hypercholesterolemia and hyperlipoproteinemia. FDA’ has granted fast track designation and Orphan-drug designation for one of these new drugs. For more information, click here.
In its office order dated 31 March 2016, the Indian Patent Office has stated that an auto-allotment system for allotting patent applications to examiners will be implemented. The order further states that FERs for patent applications will be sent to the applicants or their agents through e-mail only. For more information, please check here.
In our previous article we discussed about some freaky patents for the fashion freaks and now in this article we are discussing about some seriously funny patents. Do you have any ideas like these patented ideas?!?! Come to Prometheus to get them patented. One can never say which idea will be commercially successful.
Samsung Electronics has acquired a large number of graphene patents with more than 490 followed by China’s Ocean’s King Lighting Science & Technology and IBM Corp. Based on the naming of graphene as skinniest and strong material known, researchers believe its future use to make unbreakable screens for mobile devices [more].
Hepatitis C patients have been protesting for past one week outside India’s patent office in Dwarka against Gilead Sciences and the United States government for forcing the Indian government “to blindly and speedily grant patents”. IPO is in the process of hearing the company’s patent claim on the drug Sovaldi, with an astounding price of $84,000 (about Rs.57 lakh) in the U.S [more].
In Nashik, grape growers have presented their demands with stress on the need for Rs 40 crore funds for the purpose of importing patent varieties of table grapes. Also, duty waiver on the import of plastic covers to protect vineyards from unseasonal rainfall and hailstorm has been put on demand [more].
As per the office order dated 19th Feb 2016 issued by the office of the Controller General of Patents, Trademarks and Designs, after having kept in abeyance the guidelines for Examination of Computer Related Inventions have been finalized after having consulted the stakeholders, experts and academic institutions [More]. Our earlier article on draft guidelines with reference to section 3(k) is given here.
Patents are not all that serious business. Prometheus will bring out a series of articles on freaky patents for our blog readers. Having offbeat ideas like these patented ideas. Come to Prometheus to get them patented. One can never say which idea will be commercially successful.
James Wolter, a retired professor from Grand Valley State University and avid inventor is also a manifold patent winner, and recently received a second patent on his invention for creating a sustainable way to use energy. All his work is aimed at creating healthier energy, with efficient employment and making it more accessible to people all over the world. [more]
The German inventor of the synchronized camera flash, Artur Fischer, who registered more than 1,100 patents in his lifetime thus beating Thomas Edison passed away in Germany on January 27th, 2016 at the age of 96 years. As per The New York Times, Fischer obtained a patent for the synchronized flash system in 1947 that was developed in his attempt to have his newborn daughter photographed. [more]
Lilly has lost the latest round in an enduring legal fight over patents casing the administration of vitamins in conjunction with its epic lung cancer drug, Alimta (pemexetred). According to UK High Court, Lilly’s Alimta vitamin regimen patent would not be infringed by Allergan marketing its drug in the UK, France, Italy and Spain with instructions to dilute the product only with dextrose solution. [more]
As per the leading international authority on the disease, the involved cost of revolutionary and immensely expensive new cancer drugs could be reduced by governments by lengthening the involved patents. Dr Vishva Dixit stated on a visit to Dublin, that the cost of potentially lifesaving treatments should not be an obstruction to access.[more]
A patent involving CRISPR has been issued to a biotech startup, Caribou Biosciences in Berkeley, which was co-founded by Jennifer Doudna. The University of California, Berkeley, scientist stated that the CRISPR was invented along with French microbiologist Emmanuelle Charpentier, and the claim was disputed by rival researcher, Feng Zhang of the Broad Institute and the Massachusetts Institute of Technology. Zhang’s CRISPR patents were issued first and are licensed to the recently established public therapeutics company, Editas Medicine, among others. [more]
A divisional patent application filed by GSK at the Kolkata patent office was rejected on the grounds that composition, manufacturing method, its use and method of treatment falls within the definition of single inventive concept. The authority also alleged that the claims of the divisional application were similar to that of the mother application. [More]
The very novel patent entitled “Athletic performance user interface”, is going to impart a coach under the wearer’s feet in terms of developing a smart shoe by possessing the ability of measuring one’s athletic performance. It is proposed that the shoe will be equipped with sensors to help measure things such as speed, acceleration, direction of motion and things of that nature [more].
Horizon Pharma has announced receiving of a Notice of Allowance from the United States Patent and Trademark Office for U.S. patent application number 14/816,674 (U.S. publication number 2015-0335605), entitled “Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs”. The patent covers Horizon’s U.S. approved medicine RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid. The notice states the substantive examination of the patent application and will only result in the issuance of a U.S. patent after completion of the administrative processes [more].
According to the latest intellectual property rankings, Apple has been awarded 1,938 U.S. patents in 2015 thus placing it at No. 11 with respect to newly earned inventions. In the top was perennial intellectual property leader IBM, which was awarded 7,355 patents in 2015 and the second place holder was Samsung, with 5,072 U.S. patents [more].
Release of suit against AngioDynamics was not declared by a Delaware district court judge over patents for devices installed below the skin for effortlessness drug delivery. C.R. Bard Inc. stated that AngioDynamics had infringed on patents issued in 2013 and 2014 and AngioDynamics further added the claims as ineligible to be patented due to loss of description of specific items that can be patented [more].
IIa Technologies Pte Ltd, a synthetic diamond manufacturing company co-founded by Mumbai-based Vishal Mehta is facing litigation from De Beers subsidiary and accused by Element Six Technologies Ltd, for alleged infringement of its patents for proprietary synthetic diamond products. The infringing company was able to produce purest and rarest form of diamond – called type IIa through microwave plasma chemical vapor deposition (MPCVD) process after 8 years of RandD [more].
Iowa State University has been granted 31 patents in 2014 and coupled with the University of South Carolina and the University of Arkansas on the list of top 100 universities around the world granted utility patents. As per the president, Steven Leath, an extensive assortment of “technology transfer” is involved in the 31 patents [more].
3M has filed a patent infringement lawsuit against Xpel Technologies Corp., a San Antonio-based company that deals with manufacturing of films to protect auto paint and headlights. It has been alleged in the lawsuit that Xpel’s XPF paint protection film infringes on one of the 3M patents [more].
In December 2015, Microsoft sued Corel over infringement of nine of its patents. Some of Corel’s applications such as Corel Write and Corel Calculate are using Microsoft’s patented technologies as per Microsoft. One of the patents was a software slider that enables users to quickly zoom-in and zoom-out [more].
The biopharmaceutical company has attained an elite worldwide license to several patents from the nonprofit Research Development Foundation (RDF), and the company develops gene therapy treatments for congestive heart failure and other chronic diseases. Along with group of patents, Renova Therapeutics’ has expanded its portfolio in the cardiovascular and metabolic disease space, thus imparting future road for its paracrine gene therapy product pipeline [more]
The granted US patents defend the company’s own 4D respiratory tracking technology, which permits its SPiN Thoracic Navigation System in efficiently tracking a patient’s respiration during navigational procedures. Veran CEO Jason Pesterfield stated that the patented technology (new software) will fundamentally assist lung specialists in targeting solitary pulmonary nodules (SPN’s) and more quickly diagnose patients with lung cancer as compared to several other procedures [more].
USPTO had issued Patent 5,718,632 in 1998, on a method for avoiding “unnecessary wastage of time” in video games. The patent expired on November 27, which has finally generated immense excitement for the game players and has left inspiration for Loading Screen Jam, the place where developers craft their own loading screen games [more].
The merger, announced in early December, union between two of America’s largest, oldest and most research-oriented organizations and they are set to make huge waves in agriculture, materials and plastics sectors. Before the developments start to happen, DowDuPont will be for a succinct moment be one of the world’s intellectual property powerhouses with respect to patents [more].
Nobel Biocare had filed a patent infringement lawsuit, claiming that the implants which were imported from Brazil possessed “striking similarities” to the design of its NobelActive implants, which it launched in 2008 and in March 2014, Neodent had launched its line of Drive CM dental implants in the U.S [more].
Drug firm Suven Life Sciences has been granted a patent each by Eurasia, Europe, Israel and Macau for a drug used in the treatment of neuro-degenerative diseases. As of now, with the new patents, Suven has a total of 15 granted patents from Eurasia, 18 from Europe, 8 from Israel and 5 from Macau [more].
Natco Pharma Ltd and its partner Alvogen Inc. have settled a patent infringement case with US drug maker Gilead Sciences Inc., and Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ltd and Genentech Inc., thus clearing the way into the world’s largest pharmaceutical market for the Indian drug maker in terms of launching generic versions of anti-influenza drug, Tamiflu [more].
OptiBiotix Health plc, a life sciences business, which develops compounds to tackle obesity, high cholesterol and diabetes, has proclaimed filing of two new patents covering its cholesterol reducing product thus making a hike in the number of patents from nine to eleven.
A deal in the form of a memorandum of understanding (MoU) between Pakistan Customs and Intellectual Property Organization (IPO) has been made to permit IPO acquire online data for execution of actions taken by the Pakistan Customs against illegal movement of goods imported or exported.
United Cannabis Corporation has pushed provisional patent application to the next phase in terms of filing a utility patent application and PCT application with the USPTO with respect to unique combinations of pharmaceutically active cannabinoids employed for the treatment of disorders of the nervous system, immune system and cancer
Cancer Genetics Inc., a budding leader in DNA-based cancer diagnostics, proclaimed receiving a third US patent covering FHACT (US patent number 9,157,129), its proprietary FISH (fluorescent in situ hybridization) based HPV associated cancer test and the granted patent is part of a sequence of patents received for FHACT that provide protections for CGI’s proprietary capabilities for the detection of HPV-associated cancers, which include cervical, anal, head and neck, penile, and vulvar cancers.
Rubicon Genomics Inc. has emerged as a world leader with respect to preparation and selling of kits and reagents that speed up genomic analysis, including DNA sequencing, with applications for gene-based research, drug development and diagnostics after going through a tough time in the recent past.
Patent filing by research institutes promotes their research works actively to the public domain. Since the patents can be licensed, it is therefore possible to derive financial value from them for conducting further researches. As the innovations evolving from institutes come out of strong fundamental knowledge, it is highly recommended to secure the same.
As part of the agreement, Ranbaxy along with its partners Cipher Pharm and Galephar Pharma, has entered into a non-exclusive license agreement with Actavis under the Dublin-headquartered company may start selling its generic version of Absorica in the US on 27 December 2020 (nine months before the expiration of the patents in September 2021) or earlier under certain circumstances, Sun Pharma said.
In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.
Apple Inc could be facing up to $862 million in damages after a U.S. jury on Tuesday found the iPhone maker used technology owned by the University of Wisconsin-Madison’s licensing arm without permission in chips found in many of its most popular devices.
The United States Patent and Trademark Office (USPTO) published a short Federal Register notice titled Change in Practice Regarding Correction of Foreign Priority Claims.
The Open Invention Network – led by IBM, Google and 5 others – seeks a patent “no-fly zone” for open-source software. The consortium, known as the Open Invention Network, is dedicated to protecting a mode of collaborative invention. Specifically, it tries to safeguard the Linux open-source software ecosystem—software that’s written collaboratively and distributed for free—from patent licensing demands and lawsuits from any aggressor.
A $600 million patent licensing dispute over the use of Botox to treat migraine headaches has been resolved in Allergan PLC’s favor with a U.S. judge scolding Miotox LLC for making “tedious and convoluted” arguments to prove its case.
An Asian-American rock band called The Slants asked a federal appeals court last week to trademark its name even though the government says it disparages Asians.
Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced that the Company has filed a patent for systems and methods for predicting treatment outcomes from chemotherapy.
One of the world’s leading aeroplane manufacturers has come up with a radical new seat design -with split-level seating inside the cabin.
The arrangement proposed by Airbus designers would be used in a premium cabin such as business class with rows in the middle section alternating between floor level and an elevated level that is several feet higher.
Almac Discovery, a research driven oncology company that is dedicated to the discovery and development of novel and innovative approaches to the treatment of cancer, has announced that it has been granted patent protection (Patent Number 2040728) for its novel therapeutic drug, ALM201, in Europe, one of the largest Biopharmaceutical markets in the world. This adds to patent protection already granted in a further 6 countries – Australia, China, Israel, Japan, New Zealand and South Africa, strengthening the company’s growing portfolio globally.
Sandoz, a Novartis company and the global leader in biosimilars, announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen’s US-licensed Enbrel® (etanercept) – a tumor necrosis factor alpha (TNF-alpha) inhibitor.
Indian Pharmaceutical Alliance (IPA) withdrew its opposition to the patent application for Gilead Pharmasset’s Hepatitis C drug sofosbuvir, marketed as Sovaldi, after the latter entered into a voluntary licensing agreement with 11 companies to sell the generic version at a lower price.
The Global Innovation Index (GII) 2015, released yesterday, saw India ranked a disappointing 81 out of the 141 countries surveyed. Topping the list for the 5th year running is Switzerland, followed by UK and Sweden.
Drug makers BioMarin Pharmaceutical Inc. and Dr. Reddy’s Laboratories Ltd. have agreed to settle a patent dispute over BioMarin’s Kuvan’s tablets.
Tara Alvarez, a professor of biomedical engineering at NJIT, will receive an Edison Patent Award later this year from the Research & Development Council of New Jersey for a novel test she and a colleague designed to help eye doctors predict how well their patients will adapt to progressive lenses.
User-centered design will be a top priority as the U.S. Patent and Trademark Office develops its new online patent filing and viewing system, agency CIO John Owens told FedScoop.
The U.S. Patent and Trademark Office debuted a new tool that makes it easier for the public to explore the agency’s patents archive.
MBI announced its innovative biomass pretreatment patent (patent no. 9,102,964) has been issued by the USPTO.
The USPTO has launched two new programs aimed at improving patent quality by joining forces with the Japanese Patent Office (JPO) or the Korean Intellectual Property Office (KIPO) at the initial stages of the patent examination process.
A division bench of the Delhi High Court has reserved its decision on a high-profile patent case that pitted Swiss drug maker Novartis against Cipla over its respiratory drug brand Onbrez.
A patent was awarded to google for its glasses which has a unique auto adjusting capacity to detect the movement of the user and make adjustments accordingly.
India denied the patent for Pfizer on tofacitinib (a rheumatoid arthritis drug). The reason cited was the inability of the company to establish a more active therapeutic efficacy than the active compound.
The patent office guidelines issued have divided the software industry. Some say since the software as in algorithms and computer programmes are protected under copyright it is not essential to patent them whereas the other group says patents are necessary to deter the clone companies.
Suven Life Sciences had announced the grant of five patents in various countries. These patents include the class of selective 5 HT (Hydroxytryptamine) compounds relating to the treatment of cognitive impairment leading to neurodegenerative diseases
Daniel Gurney has done it again. The former racing car driver who has won at Sports car, Formula one, NASCAR and Indy car is also a car manufacturer and team owner. He was the one who started the tradition of spraying champagne while celebrating at the podium and also who placed a simple right angle extension on upper trailing edge of rear wing which increases the down force.
Gurney is now, back along with his team who has patented an engine design called “Moment cancelling 4 stroke”- exclusively designed for motorcycle applications. They aimed to create it which could be simple and compact, also being sturdy and systematic.
The engine design has two cylinders having a crankshaft individually and which turns in opposite direction. According to the theory given, the pistons, crank
In one of the most high profile celebrity cases filmmaker Ram Gopal Varma and his production house have been fined a sum of INR 10 lakhs for remaking the blockbuster “SHOLAY” thus mounting to copyright violation.
The Indian Patent Office has invited applications for the Trade Marks Agent Examination 2015 to be held shortly. The last date for receipt of the applications is 7th Sep 2015. After scrutiny of the applications, the IPO would post the list of eligible candidates and the date of the written exam and interview on or before 11th Sep 2015 in its official website. The written exam and the interview will be held at Mumbai.
The Controller General has issued an order affirming that for examination of patent applications relating to the field of computer related inventions (CRIs), under Section 3(k) of the Patents Act, the provisions of Guidelines for examination of CRIs are applicable with immediate effect.
The Indian Patent Office has recently issued a clarification on the Designs Act, 2000. The circular states that for registration of designs, one application would suffice for any one or all of the articles that are categorised under the same class, irrespective of the sub classes. For more information, please check out the circular in the following link:
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced that the U.S. Patent and Trademark Office has issued to the Company patent 9,096,827 titled “Adherent Cells From Placenta Tissue and Use Thereof in Therapy”. The patent protects specific methods of culturing placental adherent stromal cells, and use of these cells for the treatment of a wide variety of diseases.
The United States Patent and Trademark Office (USPTO) has recently granted US Patent No. 9080184 entitled “Transgenic Therapeutic Stem Cells and Methods for Their Use and Manufacture” to Stemedica Cell Technologies Inc. This patent contains extra amount of human granulyotic colony thus offering neuroprotection as well as neurogenesis.
The company claims that the claimed water soluble fertilizer which being a clean technology addresses the concerns about the toxicity, safety and the environment issues facing the world and thus is a decent replacement to the synthetic fertilizers.
The FDA has approved the world’s first 3D printed drug for the treatment of epilepsy. The new drug, Spritam, was developed by Aprecia Pharmaceuticals to control seizures brought on by epilepsy. The 3D technology allows Spritam (levetiracetam) to have higher manufacturing precision thus accommodating a higher dose almost upto 1000 mg in each tablet. As each drug will be completely uniform, it also means doses are more consistent.
Although the FDA has previously approved 3D-printed medical devices, this is the first time a 3D-printed product has been approved for use inside the human body.
Spritam is expected to be available in the first quarter of 2016.
India successfully protected its traditional knowledge by stalling a leading UK-based laboratory’s move to patent a medicinal composition containing turmeric, pine bark and green tea for treating hair loss.
The UK-based company – Pangaea Laboratories Limited – had filed the patent application in February, 2011. The Traditional Knowledge Digital Library (TKDL) of the Council of Scientific and Industrial Research (CSIR) could manage to prove the European Patent Office (EPO) that turmeric, pine bark and green tea have been used since time immemorial as an effective treatment for hair loss in the indigenous systems like Ayurveda and Unani. Once the patent application was published in the EPO website the CSIR-TKDL unit had objected and filed an evidence on January 13, 2014. Based on India’s evidence, the patent application was finally “deemed to
Suven Life Sciences Ltd. from Hyderabad had announced the grant of one product patent from Mexico (No: 325948 and Title: Bicyclic compounds as ligands of the nicotinic receptor beta 2 acetylcholine alpha 4) and one product patent from Singapore (No: 180674 and Title: Bicyclic compounds as alpha-4-beta-2 nicotinic acetylcholine receptor ligands) that cover New Chemical Entities (NCEs) for the treatment of neurodegenerative disorders. The NCEs belong to the class of selective alpha-4-beta-2 compounds, being developed as therapeutic agents for major depressive disorders (MDD).
Google has announced a “Patent purchase promotion” initiative that is an experimental marketplace for patents. Google would open a streamlined portal from May 8, 2015 to May 22, 2015 through which patent holders can submit offers for selling their patents to google. The patent holders can set the price and by June 26, 2015, google would review the patents and let the patent holders know whether it is interested in acquiring the patents.